Tata Chemicals Ltd (TATACHEM) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- Tata Chemicals reported a consolidated revenue of 3,509 crore, EBITDA of 327 crore, and a PAT (before exceptional items) of -12 crore for Q4 FY25.
- Standalone revenue for Q4 FY25 was 1,219 crore, with an EBITDA of 230 crore and PAT from continuing operations of 97 crore.
- Consolidated full-year FY25 revenue reached 14,088 crore, EBITDA was 1,953 crore, and PAT (before exceptional items) was 479 crore.
- Standalone full-year FY25 revenue was 4,441 crore, EBITDA was 818 crore, and PAT from continuing operations reached 524 crore.
- Higher volumes in India drove improved performance, offset by lower realizations in soda ash and bicarb.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.